Semaglutide and Tirzepatide work to promote weight loss by reducing appetite, increasing feelings of fullness, and slowing down stomach emptying
The study did, however, also highlighted several negative side effects, including constipation (118 occurrences), diarrhea (100 events), and abdominal pain (41 events per 1,000) ( Abdominal pain, nausea, vomiting, and diarrhea are among the gastrointestinal adverse effects linked to GLP-1 RAs
Even those who stayed on the medication for a full year averaged about 12% weight loss, below the 15-20% seen in trials
8 Challenges, limitations, and future directions Despite significant advances in understanding how the gut, immune system, and brain interact in PD, several challenges limit the translation of these insights into clinical practice
Handling : Avoid excessive agitation of the vial after reconstitution to prevent peptide degradation
You may need to wait for a referral and this could take several months